Evidence map›Paper›PMID 24632839›Full record

ArticlePloS one2014

The toxoplasma Acto-MyoA motor complex is important but not essential for gliding motility and host cell invasion.

Saskia Egarter, Nicole Andenmatten, Allison J Jackson, Jamie A Whitelaw, Gurman Pall, Jennifer Ann Black, David J P Ferguson, Isabelle Tardieux, Alex Mogilner, Markus Meissner

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Centrocone Protein SMC_N1 Is Important for the Proliferation ofAnimals : an open access journal from MDPI · 2026
    Article
  5. Review
  6. Article
  7. Luminal acetylation of microtubules is not essential forMicrobial cell (Graz, Austria) · 2025
    Article
  8. Article
  9. Motility-dependent processes inbioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Saskia EgarterWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Nicole AndenmattenWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Allison J JacksonWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Jamie A WhitelawWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Gurman PallWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Jennifer Ann BlackWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
David J P FergusonNuffield Department of Clinical Laboratory Science, Oxford University, Oxford, United Kingdom.
Isabelle TardieuxInstitut Cochin, University of Paris Descartes, INSERM U-1016, CNRS UMR-8104, Paris, France.
Alex MogilnerDepartment of Neurobiology, Physiology, and Behavior and Department of Mathematics, University of California Davis, Davis, California, United States of America.
Markus MeissnerWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Wellcome Trust · GBWellcome Centre for Molecular Parasitology · GBScience Oxford · GBUniversité Paris Cité · FRUniversity of California, Davis · US

Funding

Modeling mitotic spindle assemblyR01GM068952 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI MOGILNER, ALEXANDER · 2003 to 2014
$4.4M
NIGMS NIH HHS R01 GM068952Wellcome Trust 085349Wellcome Trust 087582Wellcome Trust 087582/Z/08/ZWellcome Trust 104111
6 · The paper itself

Abstract

Apicomplexan parasites are thought to actively invade the host cell by gliding motility. This movement is powered by the parasite's own actomyosin system, and depends on the regulated polymerisation and depolymerisation of actin to generate the force for gliding and host cell penetration. Recent studies demonstrated that Toxoplasma gondii can invade the host cell in the absence of several core components of the invasion machinery, such as the motor protein myosin A (MyoA), the microneme proteins MIC2 and AMA1 and actin, indicating the presence of alternative invasion mechanisms. Here the roles of MyoA, MLC1, GAP45 and Act1, core components of the gliding machinery, are re-dissected in detail. Although important roles of these components for gliding motility and host cell invasion are verified, mutant parasites remain invasive and do not show a block of gliding motility, suggesting that other mechanisms must be in place to enable the parasite to move and invade the host cell. A novel, hypothetical model for parasite gliding motility and invasion is presented based on osmotic forces generated in the cytosol of the parasite that are converted into motility.

Indexed as

Host-Pathogen InteractionsLocomotionGene Knockout TechniquesMembrane ProteinsNonmuscle Myosin Type IIANonmuscle Myosin Type IIBPhenotypeProtozoan ProteinsToxoplasmaMembrane ProteinsNonmuscle Myosin Type IIANonmuscle Myosin Type IIBProtozoan Proteins

Identifiers

PMID24632839
PMCPMC3954763
OpenAlexW2953300746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.